Skip to content

DROR ORTHO-DESIGN

OTC PINK: DROR

Company: Dror Ortho-Design
Ticker: OTC PINK: DROR
Sector: Healthcare
Investor Contact: Ben Shamsian

DROR Financials

Financials – Current & Historical

CONSOLIDATED BALANCE SHEETS
v3.25.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash $ 549,444 $ 3,347,843
Receivables and prepaid expenses 89,139 114,100
Total Current Assets 638,583 3,461,943
Non-current Assets:    
Property and equipment at cost, net of accumulated depreciation 24,142 2,328
Total Assets 662,725 3,464,271
Current Liabilities:    
Accounts payable 215,359 106,833
Accrued expenses and other payables 171,379 190,271
Registration Rights Agreement liability 520,000
Total Current Liabilities 906,738 297,104
Non-current Liabilities:    
Accrued severance 123,981 5,243
Total Liabilities 1,030,719 302,347
Commitments and Contingencies (Note 10)
Stockholders’ Equity    
Preferred A Stock, $0.0001 par value, 12,500,000 shares authorized; 5,847,937 and 10,463,363 shares outstanding at December 31, 2024 and 2023, respectively 585 1,047
Common stock, $0.0001 par value; 3,254,475,740 and 500,000,000 shares authorized; 956,997,116 and 495,454,546 shares issued and outstanding at December 31, 2024 and 2023, respectively 95,699 49,545
Additional paid-in capital 19,042,378 16,842,037
Accumulated deficit (19,506,656) (13,730,705)
Total Stockholders’ Equity (Deficiency) (367,994) 3,161,924
Total Liabilities and Stockholders’ Equity (Deficiency) $ 662,725 $ 3,464,271
CONSOLIDATED BALANCE SHEETS (PARENTHETICALS)
v3.25.0.1
Consolidated Balance Sheets (Parentheticals) - $ / shares
Dec. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Preferred A Stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred A Stock, shares authorized 12,500,000 12,500,000
Preferred A Stock, shares outstanding 5,847,937 10,463,363
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 3,254,475,740 500,000,000
Common stock, shares issued 956,997,116 495,454,546
Common stock, shares outstanding 956,997,116 495,454,546
CONSOLIDATED STATEMENTS OF INCOME
v3.25.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating Expenses    
Research and development $ 1,540,097 $ 1,063,470
General and administrative expenses 1,437,832 1,061,399
Share-based compensation 2,246,033 2,253,793
Total Operating Expenses 5,223,962 4,378,662
Loss from operations (5,223,962) (4,378,662)
Financial income (expense), net (31,989) 90,147
Gain on retirement of royalty accrual 720,632
Registration Rights Agreement expense (520,000)
Total other income (expense) (551,989) 810,779
Loss before provision for income taxes (5,775,951) (3,567,883)
Provision for income taxes
Net loss $ (5,775,951) $ (3,567,883)
Basic (in Dollars per share) $ (0.01) $ (0.01)
Diluted (in Dollars per share) $ (0.01) $ (0.01)
Basic (in Shares) [1] 672,511,484 296,664,409
Diluted (in Shares) [1] 672,511,484 296,664,409
[1] The number of shares of Common and Preferred A Stock outstanding were retroactively adjusted as a result of the Share Exchange. See Note 1
CONSOLIDATED STATEMENTS OF CASH FLOWS
v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (5,775,951) $ (3,567,883)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation expense 2,246,033 2,253,793
Gain on retirement of royalty accrual (720,632)
Depreciation 4,035 670
Foreign exchange differences 26,703 (90,147)
Changes in operating assets and liabilities:    
Receivables and prepaid expenses 24,961 (7,264)
Accounts payable 112,551 44,111
Accrued expenses and other payables (18,892) (110,231)
Registration Rights Agreement liability 520,000
Founders claim accrual (207,844)
Accrued royalties 6,438
Accrued severance 118,738 4,827
Net cash used in operating activities (2,741,822) (2,394,162)
Cash flows from investing activities:    
Cash acquired in reverse recapitalization 17,966
Purchase of property and equipment (25,849)
Net cash provided by (used in) investing activities (25,849) 17,966
Cash flows from financing activities:    
Proceeds from private placement raise 5,225,000
Issuance costs (571,796)
Net cash provided by financing activities 4,653,204
Effect of exchange rate changes on cash (30,728) 31,776
Net increase (decrease) in cash (2,798,399) 2,308,784
Cash, beginning of year 3,347,843 1,039,059
Cash, end of year 549,444 3,347,843
Supplemental cash flow information:    
Cash paid for interest
Cash paid for taxes
Non-cash activities:    
Shares issued at reverse recapitalization 20,231
Net liabilities assumed in reverse recapitalization 791,232
Return of founders shares to the Company as part of claim settlement 33,096
Settlement of Treasury Stock prior to recapitalization $ 33,096
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY (DEFICIENCY)
v3.25.0.1
Consolidated Statements of Changes in Stockholders’ Equity (Deficiency) - USD ($)
Preferred Stock
Series A
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 758 $ 43,774 $ 10,714,366 $ (10,162,822) $ 596,076
Balance (in Shares) at Dec. 31, 2022 7,576,999 [1] 437,735,093 [1]      
Return of founders shares to the Company as part of claim settlement $ (33,096) $ 33,096
Return of founders shares to the Company as part of claim settlement (in Shares) (330,952,906) 330,952,906      
Private Placement Investment, net of issuance costs $ 289 $ 18,636 4,634,279 4,653,204
Private Placement Investment, net of issuance costs (in Shares) 2,886,364 [1] 186,363,631        
Settlement of Treasury Stock prior to recapitalization $ (33,096) 33,096
Settlement of Treasury Stock prior to recapitalization (in Shares)     (330,952,906)      
Reverse re-capitalization $ 20,231 (793,497) (773,266)
Reverse re-capitalization (in Shares)   202,308,728        
Stock-based compensation 2,253,793 2,253,793
Net loss (3,567,883) (3,567,883)
Balance at Dec. 31, 2023 $ 1,047 $ 49,545 16,842,037 (13,730,705) 3,161,924
Balance (in Shares) at Dec. 31, 2023 10,463,363 [1] 495,454,546 [1]      
Stock-based compensation 2,246,033 2,246,033
Conversion of Series A Preferred Stock into Common Stock $ (462) $ 46,154 (45,692)
Conversion of Series A Preferred Stock into Common Stock (in Shares) (4,615,426) 461,542,570        
Net loss (5,775,951) (5,775,951)
Balance at Dec. 31, 2024 $ 585 $ 95,699 $ 19,042,378 $ (19,506,656) $ (367,994)
Balance (in Shares) at Dec. 31, 2024 [1] 5,847,937 956,997,116        
[1] The number shares of Common and Preferred A Stock outstanding were retroactively adjusted as a result of the Share Exchange. See Note 1
Arrow